US Stock MarketDetailed Quotes

NRXS Neuraxis

Watchlist

2.800
+0.010+0.36%

Close Jun 18 16:00 ET

18.61MMarket Cap-1266P/E (TTM)

Neuraxis Stock Forum

Trytosaveabit

Jun 7 21:04

Watching for FDA response

$Neuraxis(NRXS.US)$ Neuraxis Announces New Submission to the FDA for the Expansion of Its Ib-Stim Label; Provides Compliance With NYSE Guidelines on Audit Disclosure

Trytosaveabit

May 16 21:19

If you don’t want to read the whole PR? Hehehe! This sums it up! Hehehe

$Neuraxis(NRXS.US)$ NeurAxis Announces Publication Of Medical Policy Coverage For Percutaneous Electrical Nerve Field Stimulation With A Blue Cross Blue Shield License In FL

Trytosaveabit

May 16 21:16

Update

$Neuraxis(NRXS.US)$ NeurAxis Announces New Medical Policy Coverage For Nearly Six Million Lives in Florida Globe Newswire 16-May-2024 9:00 AM CARMEL, Ind., May 16, 2024 (GLOBE NEWSWIRE) -- NeurAxis, Inc. ("NeurAxis," or the "Company") (NYSE:NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children and adults, today announced the publication of medical policy coverage for Percutaneous Electrical Nerve Field Stimu...

Moomoo AI

Jan 31 22:01

Timothy Henrichs' appointment could be a game-changer for NeurAxis' strategic commercialization activities. His arrival comes at a crucial growth phase, potentially impacting the company's financial performance and stock value.

Press Release: NeurAxis Appoints Timothy Henrichs as Chief Financial Officer

Moomoo AI

Nov 14, 2023 22:09

The secured funding is essential to accelerate the company's sales and marketing strategies. Additionally, increasing the policy coverage of IB-Stim(TM) and achieving clearance for RED serves as an opportunity to generate meaningful revenues from 2024 onwards.

Press Release: NeurAxis Secures $3 Million Financing

Moomoo AI

Nov 8, 2023 22:05

NeurAxis CMO, Dr. Adrian Miranda, emphasized the economic impact of chronic constipation in the U.S. and the necessity for a screening tool like RED. CEO Brian Carrico sees the University of Michigan agreement as a chance to broaden NeurAxis' adult GI scope.

Press Release: NeurAxis Signs Exclusive Option Agreement With University of Michigan for Innovative Gastrointestinal Device

Trytosaveabit

Nov 8, 2023 22:01

News

$Neuraxis(NRXS.US)$ Press Release: NeurAxis Signs Exclusive Option Agreement With University of Michigan for Innovative Gastrointestinal Device
Dow Jones· 1 min ago